GGrantIndex
← Search

CHARACTERIZING NITRO-FATTY ACIDS AS RAD51 INHIBITORS AND COTREATMENT IN TRIPLE-NEGATIVE BREAST CANCER.

$1,019,475FY2019Department of the ArmyDOD

University Of Pittsburgh - Of The Commonwealth System Of Higher Education

Investigators

View source on USAspending →
CHARACTERIZING NITRO-FATTY ACIDS AS RAD51 INHIBITORS AND COTREATMENT IN TRIPLE-NEGATIVE BREAST CANCER. · GrantIndex